Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Generation of a human iPSC line from a patient with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutation in SACSIN gene

CM. Arellano, A. Vilches, E. Clemente, SI. Pascual-Pascual, A. Bolinches-Amorós, AA. Castro, C. Espinos, ML. Rodriguez, P. Jendelova, S. Erceg,

. 2018 ; 31 (-) : 249-252. [pub] 20180727

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012435

The human iPSC cell line, ARS-FiPS4F1 (ESi063-A), derived from dermal fibroblast from the patient autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutations on the gene SACSIN, was generated by non-integrative reprogramming technology using OCT3/4, SOX2, CMYC and KLF4 reprogramming factors. The pluripotency was assessed by immunocytochemistry and RT-PCR. Differentiation capacity was verified in vitro. This iPSC line can be further differentiated toward affected cells to better understand molecular mechanisms of disease and pathophysiology.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012435
003      
CZ-PrNML
005      
20190408131723.0
007      
ta
008      
190405s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.scr.2018.07.012 $2 doi
035    __
$a (PubMed)30144656
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Arellano, Candela Machuca $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigacion Principe Felipe (CIPF), Valencia, Spain.
245    10
$a Generation of a human iPSC line from a patient with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutation in SACSIN gene / $c CM. Arellano, A. Vilches, E. Clemente, SI. Pascual-Pascual, A. Bolinches-Amorós, AA. Castro, C. Espinos, ML. Rodriguez, P. Jendelova, S. Erceg,
520    9_
$a The human iPSC cell line, ARS-FiPS4F1 (ESi063-A), derived from dermal fibroblast from the patient autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutations on the gene SACSIN, was generated by non-integrative reprogramming technology using OCT3/4, SOX2, CMYC and KLF4 reprogramming factors. The pluripotency was assessed by immunocytochemistry and RT-PCR. Differentiation capacity was verified in vitro. This iPSC line can be further differentiated toward affected cells to better understand molecular mechanisms of disease and pathophysiology.
650    _2
$a mladiství $7 D000293
650    _2
$a buněčné linie $7 D002460
650    _2
$a lidé $7 D006801
650    _2
$a indukované pluripotentní kmenové buňky $x metabolismus $7 D057026
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a svalová spasticita $x genetika $7 D009128
650    _2
$a mutace $7 D009154
650    _2
$a spinocerebelární ataxie $x vrozené $x genetika $7 D020754
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vilches, Angel $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigacion Principe Felipe (CIPF), Valencia, Spain.
700    1_
$a Clemente, Eleonora $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigacion Principe Felipe (CIPF), Valencia, Spain.
700    1_
$a Pascual-Pascual, Samuel Ignacio $u Servicio de Neuropediatría, Hospital Universitario La Paz, Madrid, Spain.
700    1_
$a Bolinches-Amorós, Arantxa $u National Stem Cell Bank-Valencia Node, Biomolecular and Bioinformatics Resources Platform PRB2, ISCIII, Research Centre Principe Felipe, c/ Eduardo Primo Yúfera 3, 46012 Valencia, Spain.
700    1_
$a Castro, Ana Artero $u National Stem Cell Bank-Valencia Node, Biomolecular and Bioinformatics Resources Platform PRB2, ISCIII, Research Centre Principe Felipe, c/ Eduardo Primo Yúfera 3, 46012 Valencia, Spain.
700    1_
$a Espinos, Carmen $u Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Service of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
700    1_
$a Rodriguez, Marian Leon $u National Stem Cell Bank-Valencia Node, Biomolecular and Bioinformatics Resources Platform PRB2, ISCIII, Research Centre Principe Felipe, c/ Eduardo Primo Yúfera 3, 46012 Valencia, Spain.
700    1_
$a Jendelova, Pavla $u Institute of Experimental Medicine, Department of Tissue Cultures and Stem Cells, Academy of Science of the Czech Republic, Prague, Czech Republic.
700    1_
$a Erceg, Slaven $u Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigacion Principe Felipe (CIPF), Valencia, Spain; National Stem Cell Bank-Valencia Node, Biomolecular and Bioinformatics Resources Platform PRB2, ISCIII, Research Centre Principe Felipe, c/ Eduardo Primo Yúfera 3, 46012 Valencia, Spain; Institute of Experimental Medicine, Department of Tissue Cultures and Stem Cells, Academy of Science of the Czech Republic, Prague, Czech Republic. Electronic address: serceg@cipf.es.
773    0_
$w MED00167579 $t Stem cell research $x 1876-7753 $g Roč. 31, č. - (2018), s. 249-252
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30144656 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190408131737 $b ABA008
999    __
$a ok $b bmc $g 1391745 $s 1050740
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 31 $c - $d 249-252 $e 20180727 $i 1876-7753 $m Stem cell research $n Stem Cell Res $x MED00167579
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...